Archive for May 10, 2008

Who Is Steering the Ship? External Influences on Infection Control Programs

Clinical Infectious Diseases  1 Jun 2008  V.46  N.11  p.1746–1750


Michael Edmond1 and Theodore C. Eickhoff2

1Virginia Commonwealth University School of Medicine, Richmond; 2University of Colorado School of Medicine, Denver

FREE Full Text (CLIC en PDF version)

May 10, 2008 at 6:17 pm Leave a comment

Long-Term Effects of Highly Active Antiretroviral Therapy on CD4+ Cell Evolution among Children and Adolescents Infected with HIV: 5 Years and Counting

Clinical Infectious Diseases  1 Jun 2008  V.46  N.11  p.1751–1760

Kunjal Patel,1,3 Miguel A. Hernán,1 Paige L. Williams,2,3 John D. Seeger,5 Kenneth McIntosh,4 Russell B. Van Dyke,6 and George R. Seage III,1,3 for the Pediatric AIDS Clinical Trials Group 219/219C Study Teama

Departments of 1Epidemiology and 2Biostatistics, Harvard School of Public Health, 3Center for Biostatistics in AIDS Research, and 4Harvard Medical School, Children’s Hospital, Boston, and 5i3 Drug Safety, Auburndale, Massachusetts; and 6Department of Pediatrics, Tulane University Health Sciences Center, New Orleans, Louisiana

FREE Full Text (CLIC en PDF version)

May 10, 2008 at 6:15 pm Leave a comment

Human Rabies Prevention — United States, 2008

MMWR  Early Release  May 7, 2008  V.57  p.1-26,28

Recommendations of the Advisory Committee on Immunization Practices

FREE Full Text

May 10, 2008 at 6:14 pm Leave a comment

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

JAMA  7 May 2008  V.299  N.17  p.2056-2065

Christina R. Phares, PhD; Ruth Lynfield, MD; Monica M. Farley, MD; Janet Mohle-Boetani, MD; Lee H. Harrison, MD; Susan Petit, MPH; Allen S. Craig, MD; William Schaffner, MD; Shelley M. Zansky, PhD; Ken Gershman, MD; Karen R. Stefonek, MPH; Bernadette A. Albanese, MD; Elizabeth R. Zell, MStat; Anne Schuchat, MD; Stephanie J. Schrag, DPhil

 Epidemic Intelligence Service Program, Office of Workforce and Career Development (Dr Phares) and Respiratory

Diseases Branch (Drs Phares, Schuchat, and Schrag) and Biostatistics and Information Management Branch (Ms Zell), Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Minnesota Department of Health, St Paul (Dr Lynfield); Emory University School of Medicine and Atlanta VA Medical Center, Georgia Emerging Infections Program, Atlanta, Georgia (Dr Farley); Infectious Diseases Branch, California Department of Health Services, Richmond (Dr Mohle-Boetani); Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (Dr Harrison); Emerging Infections Program, Connecticut Department of Public Health, Hartford (Ms Petit); Tennessee Department of Health, Nashville (Dr Craig); Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (Dr Schaffner); New York State Department of Health, Albany (Dr Zansky); Colorado Department of Public Health and Environment, Denver (Dr Gershman); Oregon Public Health Services, Portland (Ms Stefonek); and New Mexico Department of Health Emerging Infections Program, Santa Fe (Dr Albanese).


May 10, 2008 at 6:13 pm Leave a comment

Acute Febrile Respiratory Illness in the ICU*

Chest  May 2008  V.133  N.5  p.1221–1231

Reducing Disease Transmission

Christian Sandrock, MD, MPH, FCCP and Nicholas Stollenwerk, MD

* From the Division of Pulmonary and Critical Care Medicine (Dr. Stollenwerk), Division of Infectious Diseases (Dr. Sandrock), University of California, Davis School of Medicine, Sacramento, CA.


May 10, 2008 at 6:11 pm Leave a comment

Clinical Utility of the QuantiFERON TB-2G Test for Elderly Patients With Active Tuberculosis*

Chest  May 2008  V.133  N.5  p.1196–1202

Yoshihiro Kobashi, MD, PhD; Keiji Mouri, MD; Shinich Yagi, MD; Yasushi Obase, MD, PhD; Naoyuki Miyashita, MD, PhD; Niro Okimoto, MD, PhD; Toshiharu Matsushima, MD, PhD; Takeshi Kageoka, MD, PhD and Mikio Oka, MD, PhD

* From the Division of Respiratory Diseases (Drs. Kobashi, Mouri, Yagi, Obase, Miyashita, and Oka), Department of Medicine, Kawasaki Medical School, Kurashiki, Japan; the Division of Respiratory Diseases (Dr. Okimoto), Department of Medicine, Kawasaki Medical School Kawasaki Hospital, Okayama, Japan; the Division of Respiratory Diseases (Dr. Matsushima), Kurashiki Daiichi Hospital, Oimatsuchou, Kurashiki, Japan; and the Department of Laboratory Division, Kurashiki Central Hospital, Kurashiki, Japan.


May 10, 2008 at 6:09 pm Leave a comment

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin-Structure Infections Caused by Gram-Positive Organisms

Clinical Infectious Diseases  1 Jun 2008  V.46  N.11  p.1683–1693

Martin E. Stryjewski,1,9 Donald R. Graham,3 Samuel E. Wilson,4 William O’Riordan,5 David Young,6 Arnold Lentnek,8 Douglas P. Ross,10 Vance G. Fowler,1,2 Alan Hopkins,7 H. David Friedland,7 Steven L. Barriere,7 Michael M. Kitt,7 and G. Ralph Corey,1,2 on behalf of the Assessment of Telavancin in Complicated Skin and Skin-Structure Infections Study a

1Duke Clinical Research Institute and 2Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina; 3Springfield Clinic, Springfield, Illinois; 4University of California, Irvine School of Medicine, Orange, 5eStudy Site, San Diego, 6San Francisco General Hospital–University of California, San Francisco, and 7Theravance, South San Francisco, California; 8WellStar Health System, Marietta, Georgia; 9Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires CEMIC, Argentina; and 10St. Mary’s Hospital, Durban, South Africa


May 10, 2008 at 6:08 pm Leave a comment


May 2008

Posts by Month

Posts by Category